Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies

Oncogenic mutations in RAS genes are very common in human cancer, resulting in cells with well-characterized selective advantages, but also less well-understood vulnerabilities. We have carried out a large-scale loss-of-function screen to identify genes that are required by KRAS-transformed colon ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Steckel, Michael, Molina-Arcas, Miriam, Weigelt, Britta, Marani, Michaela, Warne, Patricia H, Kuznetsov, Hanna, Kelly, Gavin, Saunders, Becky, Howell, Michael, Downward, Julian, Hancock, David C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411175/
https://www.ncbi.nlm.nih.gov/pubmed/22613949
http://dx.doi.org/10.1038/cr.2012.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411175/
https://www.ncbi.nlm.nih.gov/pubmed/22613949
http://dx.doi.org/10.1038/cr.2012.82

Ejemplares similares